Abstract
Variety of products and surgical approaches to stimulate biologic factors and promote osteogenesis have been developed over the years, but surgeons still face challenges relating to bone healing. This study was designed to evaluate the histopathologic effects of autologous platelet-rich plasma and cancellous bone grafts on caudolateral ulna ostectomy of Nigerian local dogs. Twelve healthy Nigerian indigenous dogs (males) were used for the study. They were randomly grouped into four viz: platelet-rich plasma-treated group (PRPG) (n = 3), cancellous bone graft-treated group (CBG) (n = 3), platelet-rich plasma/cancellous bone graft-treated group (PRP/CBG) (n = 3), and normal saline-treated control group (CG) (n = 3). Caudolateral ulna defects were created on the left ulna of each dog under general anesthesia and treated as follows: the PRPG were treated by application of autologous PRP on the defects prior to closure, the PRP/CBG defects were treated by applying both PRP and cancellous bone grafts on the defects, and CBG was treated with autologous cancellous bone grafts alone while the control defects were treated by applying normal saline on the defects prior to closure of the soft tissues. Animals were euthanized at week 10 and the bridging callus of the defects analyzed by histopathology. The PRP defects either in combination with cancellous bone grafts or alone demonstrated more matured lamella bone compared to the CBG and control defects. The control defects were characterized with fibrocartillagenous zones of intense cellular activities mainly of chondroblasts and oeteoblasts. The mean histologic indices of the PRPG and PRP/CBG defects varied significantly (p < 0.05) with the CBG and the control defects. The results showed that the PRP has a positive osteogenic effect in treatment of caudolateral ulna ostectomies of dogs but its activity was optimal when combined with autologous cancellous bone grafts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boyan BD, Schwartz DMD, Patterson TE and Muschler G 2007 Clinical use of platelet-rich plasma in orthopedics http://www.aaos.org/news/bulletin/sep07/research2.asp
Delloye C, Verhelpen M, d’Hemricourt J, Govaerts B, Bourgois R (1992) Morphometric and physical investigations of segmental cortical bone autografts and allografts in canine ulnar defects. Clin Orthop Relat Res 282:273–292
Driver VR, Hanft J, Fylling CP, Beriou JM (2006) Autologel Diabetic Foot Ulcer Study Group; a prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomyelitis Wound Manag 52(6):68–70
Everts PA, Brown Mahoney C, Hoffmann JJ (2006) Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 24(3):165–171
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet rich plasma; from basic science to clinical applications. Am J Sports Med 37(11):2259–2272
Gogolewski S, Pineda L, Büsing CM (2000) Bone regeneration in segmental defects with resorbable polymeric membranes: IV. Does the polymer chemical composition affect the healing process? Biomaterials 21(24):2513–2520
Grundel RE, Chapman MW, Yee T, Moore DC (1991) Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop Relat Res 266:244–258
Hobbenaghi et al (2014) Histopathological features of bone regeneration in a canine segmental ulnar defect model. Diagn Pathol 9:59
Jakse N, Tangl S, Gilli R, Berghold A, Lorenzoni M (2003) Influence of PRP on autologous sinus grafts; an experimental study on sheep. Clin Oral Implants Res 14:578–583
Kanthan SR, Kavitha G, Addi S, Choon DS, Kamarul T (2011) Platelet-rich plasma enhances bone healing in non-united critical-sized defects: a preliminary study involving rabbit model. Injury 42(8):782–789
Marx RE (2001) Platelet-rich plasma (PRP): what is PRP what is not PRP? Implant Dent 10(4):225–228
Mehta V (2010) Platelet-rich plasma: a review of the science and possible clinical applications. Orthopedics 33(2):111
Millington JT, Norris TW (2000) Effective treatment strategies for diabetic foot wounds. J Fam Pract 49(11 Suppl):S40–S48
Nilsson OS, Urist MR, Dawson EG, Schmalzried TP, Finerman GAM (1986) Bone repair induced by bone morphogenic protein in ulna defect in dogs. J Bone Joint Surg 68B(4):635–642
Petrova N, Edmonds M (2006) Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs 11(4):709–724
Tabata Y (2003) Tissue regeneration based on growth factor release. Tissue Eng 9:5–15
Acknowledgments
The authors thank PlateltexR of Czech Republic for giving the Plateltex kits used for this study. The efforts made by Dr Chinwe Chukwudi in acquiring those kits were highly commendable.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nnaji, T., Kene, R., Chah, K. et al. Histopathological evaluation of the osteogenic activity of autologous platelet-rich plasma in experimentally induced ulna defect in dogs. Comp Clin Pathol 24, 1593–1597 (2015). https://doi.org/10.1007/s00580-015-2121-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-015-2121-0